NO2185155T3 - - Google Patents

Info

Publication number: NO2185155T3
Authority: NO; Norway

Application number

NO08782602A

Other languages

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-08-03

Filing date

2008-08-04

Publication date

2018-03-03

2008-08-04 Application filed filed Critical

2018-03-03 Publication of NO2185155T3 publication Critical patent/NO2185155T3/no

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Epidemiology (AREA)
Psychiatry (AREA)
Reproductive Health (AREA)
Gynecology & Obstetrics (AREA)
Endocrinology (AREA)
Hospice & Palliative Care (AREA)
Pregnancy & Childbirth (AREA)
Otolaryngology (AREA)
Psychology (AREA)
Anesthesiology (AREA)
Pain & Pain Management (AREA)
Addiction (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO08782602A 2007-08-03 2008-08-04 NO2185155T3 (lt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US95369407P	2007-08-03	2007-08-03
PCT/US2008/072066 WO2009020897A1 (en)	2007-08-03	2008-08-04	Pharmaceutical compositions containing dopamine receptor ligands and methods of treatment using dopamine recptor ligands

Publications (1)

Publication Number	Publication Date
NO2185155T3 true NO2185155T3 (lt)	2018-03-03

Family

ID=40338740

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO08782602A NO2185155T3 (lt)	2007-08-03	2008-08-04

Country Status (20)

Country	Link
US (3)	US20090036468A1 (lt)
EP (1)	EP2185155B1 (lt)
JP (1)	JP5460594B2 (lt)
KR (1)	KR101612563B1 (lt)
CN (1)	CN101815519B (lt)
AU (1)	AU2008283989B2 (lt)
CA (1)	CA2695519A1 (lt)
CY (1)	CY1119828T1 (lt)
DK (1)	DK2185155T3 (lt)
EA (1)	EA018064B1 (lt)
ES (1)	ES2653852T3 (lt)
HR (1)	HRP20171908T1 (lt)
HU (1)	HUE036004T2 (lt)
LT (1)	LT2185155T (lt)
MY (1)	MY157192A (lt)
NO (1)	NO2185155T3 (lt)
PL (1)	PL2185155T3 (lt)
PT (1)	PT2185155T (lt)
SI (1)	SI2185155T1 (lt)
WO (1)	WO2009020897A1 (lt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AP2975A (en)	2008-07-16	2014-09-30	Richter Gedeon Nyrt	Pharmaceutical formulations containing dopamine receptor ligands
WO2011060363A2 (en) *	2009-11-16	2011-05-19	Auspex Pharmaceuticals, Inc.	Cyclohexyl urea modulators of d2 receptors and/or d3 receptors
HRP20170134T1 (hr)	2010-06-18	2017-03-24	Altos Therapeutics, LLC	Antagonisti d2, metode sinteze i metode uporabe
WO2014031162A1 (en)	2012-08-20	2014-02-27	Forest Laboratories Holdings Limited	Crystalline form of carbamoyl-cyclohexane derivatives
US11274087B2 (en)	2016-07-08	2022-03-15	Richter Gedeon Nyrt.	Industrial process for the preparation of cariprazine
HUP1700253A1 (hu) *	2017-06-13	2019-01-28	Richter Gedeon Nyrt	Szilárd orális gyógyszerkészítmények
GB2571696B (en)	2017-10-09	2020-05-27	Compass Pathways Ltd	Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
US12459965B2 (en)	2017-10-09	2025-11-04	Compass Pathfinder Limited	Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
US11547707B2 (en)	2019-04-10	2023-01-10	Richter Gedeon Nyrt.	Carbamoyl cyclohexane derivatives for treating autism spectrum disorder
HU231500B1 (hu) *	2019-04-10	2024-04-28	Richter Gedeon Nyrt	Karbamoil-ciklohexán származékok autizmus spektrum betegség kezelésére
CA3138094A1 (en)	2019-04-17	2020-10-22	Compass Pathfinder Limited	Methods for treating anxiety disorders, headache disorders, and eating disorders with psilocybin
MX2024005256A (es) *	2021-10-28	2024-09-06	Abbvie Inc	Tratamiento del trastorno depresivo mayor.
WO2023114097A1 (en) *	2021-12-13	2023-06-22	Compass Pathfinder Limited	Psilocybin and an adjunctive serotonin reuptake inhibitor for use in the treatment of treatment-resistant depression
EP4493274A4 (en)	2022-03-17	2026-03-18	Mapi Pharma Ltd	DEPOSIT SYSTEMS INCLUDING CARIPRAZINE OR SALTS THEREOF

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8814057D0 (en) *	1988-06-14	1988-07-20	Lundbeck & Co As H	New enantiomers & their isolation
ZA977967B (en) *	1996-09-23	1999-03-04	Lilly Co Eli	Combination therapy for treatment of psychoses
US6960577B2 (en) *	1998-05-22	2005-11-01	Eli Lilly And Company	Combination therapy for treatment of refractory depression
US6556540B1 (en) *	1998-05-29	2003-04-29	Paradyne Corporation	System and method for non-intrusive measurement of service quality in a communications network
HRP20020344B1 (hr) *	1999-10-25	2010-10-31	H. Lundbeck A/S	Način priprave citaloprama
UA77650C2 (en) *	1999-12-06	2007-01-15	Lundbeck & Co As H	Use of serotonin reuptake inhibitor in combination with deramcyclane
CZ20033267A3 (en) *	2001-05-01	2004-06-16	H. Lundbeck A/S	The use of enantiomeric pure escitalopram
US7030122B2 (en) *	2002-04-12	2006-04-18	Sepracor Inc.	1,4-disubstituted piperazine ligands for neurotransmitter receptors
BR0311503A (pt) *	2002-06-20	2005-02-22	Lundbeck & Co As H	Uso de um composto, uso de um agonista parcial, agonista inverso, ou antagonista de receptor de gabab, composição farmacêutica, método para a identificação de compostos úteis para o tratamento de doenças, e, composto
HU227534B1 (en) *	2003-08-04	2011-08-29	Richter Gedeon Nyrt	(thio)carbamoyl-cyclohexane derivatives, process for producing them and pharmaceutical compositions containing them
CN1845730A (zh) *	2003-09-04	2006-10-11	H.隆德贝克有限公司	5－羟色胺再摄取抑制剂与克塞平的组合
HUP0500170A3 (en) *	2005-02-03	2007-11-28	Richter Gedeon Nyrt	Piperazine derivatives, process for producing them and pharmaceutical compositions containing them
TW200812993A (en) *	2006-05-02	2008-03-16	Lundbeck & Co As H	New uses of escitalopram
HU230748B1 (hu) *	2007-05-11	2018-02-28	Richter Gedeon Nyrt	Új piperazin só és előállítási eljárása

2008
- 2008-08-04 MY MYPI2010000523A patent/MY157192A/en unknown
- 2008-08-04 NO NO08782602A patent/NO2185155T3/no unknown
- 2008-08-04 HU HUE08782602A patent/HUE036004T2/hu unknown
- 2008-08-04 US US12/185,211 patent/US20090036468A1/en not_active Abandoned
- 2008-08-04 CA CA2695519A patent/CA2695519A1/en not_active Abandoned
- 2008-08-04 JP JP2010520238A patent/JP5460594B2/ja active Active
- 2008-08-04 EA EA201000280A patent/EA018064B1/ru unknown
- 2008-08-04 AU AU2008283989A patent/AU2008283989B2/en active Active
- 2008-08-04 PL PL08782602T patent/PL2185155T3/pl unknown
- 2008-08-04 PT PT87826020T patent/PT2185155T/pt unknown
- 2008-08-04 CN CN2008801062563A patent/CN101815519B/zh active Active
- 2008-08-04 EP EP08782602.0A patent/EP2185155B1/en active Active
- 2008-08-04 DK DK08782602.0T patent/DK2185155T3/en active
- 2008-08-04 WO PCT/US2008/072066 patent/WO2009020897A1/en not_active Ceased
- 2008-08-04 KR KR1020107004638A patent/KR101612563B1/ko active Active
- 2008-08-04 HR HRP20171908TT patent/HRP20171908T1/hr unknown
- 2008-08-04 SI SI200831900T patent/SI2185155T1/en unknown
- 2008-08-04 LT LTEP08782602.0T patent/LT2185155T/lt unknown
- 2008-08-04 ES ES08782602.0T patent/ES2653852T3/es active Active
2010
- 2010-09-27 US US12/890,752 patent/US20110015208A1/en not_active Abandoned
2011
- 2011-10-10 US US13/269,928 patent/US20120028991A1/en not_active Abandoned
2017
- 2017-12-07 CY CY20171101293T patent/CY1119828T1/el unknown

Also Published As

Publication number	Publication date
EP2185155A1 (en)	2010-05-19
MY157192A (en)	2016-05-13
AU2008283989B2 (en)	2013-12-05
EP2185155B1 (en)	2017-10-04
CA2695519A1 (en)	2009-02-12
EA201000280A1 (ru)	2010-08-30
ES2653852T3 (es)	2018-02-09
CN101815519A (zh)	2010-08-25
CY1119828T1 (el)	2018-06-27
KR101612563B1 (ko)	2016-04-14
PT2185155T (pt)	2018-01-04
HK1144784A1 (en)	2011-03-11
LT2185155T (lt)	2017-12-11
EA018064B1 (ru)	2013-05-30
JP2010535790A (ja)	2010-11-25
DK2185155T3 (en)	2018-01-02
CN101815519B (zh)	2013-08-21
JP5460594B2 (ja)	2014-04-02
AU2008283989A1 (en)	2009-02-12
US20120028991A1 (en)	2012-02-02
SI2185155T1 (en)	2018-02-28
US20110015208A1 (en)	2011-01-20
HUE036004T2 (hu)	2018-06-28
US20090036468A1 (en)	2009-02-05
PL2185155T3 (pl)	2018-03-30
WO2009020897A1 (en)	2009-02-12
HRP20171908T1 (hr)	2018-01-26
EP2185155A4 (en)	2012-04-25
KR20100059830A (ko)	2010-06-04

Publication	Publication Date	Title
BR122019003642A2 (lt)	2015-06-16
NO2185155T3 (lt)	2018-03-03
CN300726996S (zh)	2008-01-02	集装箱顶盖
CN300728369S (zh)	2008-01-02	电筒(节能强光防爆 jw7210)
CN300728867S (zh)	2008-01-09	椅子(3)
CN300728866S (zh)	2008-01-09	椅子(2)
CN300728855S (zh)	2008-01-09	会议椅(a-41#)
CN300877227S (zh)	2009-01-21	Led模组箱体
CN300728781S (zh)	2008-01-09	墙纸(40a)
CN300728752S (zh)	2008-01-09	墙纸(2a)
CN300728746S (zh)	2008-01-09	成串包装的食品包装纸
CN300726752S (zh)	2008-01-02	拉手(005)
CN300726844S (zh)	2008-01-02	酒瓶(团缘壶和酒)
CN300729276S (zh)	2008-01-09	气动扳手(一英寸89600)
CN300727861S (zh)	2008-01-02	笔(1000)
CN300727787S (zh)	2008-01-02	矿用硬质合金定位截煤齿
CN300727593S (zh)	2008-01-02	蓝牙耳机(xbt006)
CN300727536S (zh)	2008-01-02	开关
CN300727423S (zh)	2008-01-02	轮毂(球款)
CN300727342S (zh)	2008-01-02	摩托车卡子
CN300727312S (zh)	2008-01-02	考拉警车(eg6043k)
CN300727270S (zh)	2008-01-02	戒指(n909)
CN300874042S (zh)	2009-01-14	标贴(070635)
CN300727155S (zh)	2008-01-02	铅笔包装袋(287)
CN300729147S (zh)	2008-01-09	压力锅锅体(锅底图案3)